<DOC>
	<DOCNO>NCT02243865</DOCNO>
	<brief_summary>The purpose pilot study evaluate performance Chordate System , term prophylactic effect tolerability treatment patient diagnose migraine .</brief_summary>
	<brief_title>Chordate System Prophylactic Migraine Clinical Investigation</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>The subject legally competent , informed nature , scope relevance study , voluntarily agree participation study 's provision , duly sign Informed Consent Form ( ICF ) . Male female age 18 65 year Diagnosed suffer migraine without aura accord HIS classification ( ICHD 3rd edition , beta version ) Reported history 3 8 migraine episode per month previous 2 month , confirm baseline Reported history least 48 hour freedom headache migraine attack , confirm baseline Onset migraine headache occur age 50 Reported history migraine one year Reported stable dose prophylactic migraine medication ( ) , , two month prior screen ( visit 1 ) , willing able maintain stable dose ( ) three month followup ( visit 4 ) Meeting ICHD criterion medication overuse Reported history 15 headache day per month ( i.e . headache kind ) , confirm baseline Reported frequency nonmigraine headache exceed 6 day per month , confirm baseline Unable distinguish migraine headache headache type Treatment Botox receive within 6 month screen visit , screen treatment visit Ongoing treatment implant stimulator implanted device head and/or neck region Known pronounce anterior septal deviation , know relevant abnormality nasal cavity , include bacterial infection wound History sinus surgery , transphenoidal surgery pituitary lesion CSF rhinorrhea Fitted pacemaker/defibrillator Previously treat therapeutic radiation face ( could influence nasal mucosa ) Ongoing upper respiratory tract infection body temperature &gt; 38.5Â°C ( treatment ) , malignancy nasal cavity History regular nose bleeding ( epistaxis ) , concomitant condition could cause excessive bleeding , include treatment anticoagulant Varan Head injury open wound contraindicates use Chordate Headband Known allergy polyvinylchloride , material use Catheter , medicinal liquid paraffin Concurrent condition risk noncompliance , investigator 's opinion , may affect interpretation performance safety data otherwise contraindicate participation clinical investigation Any change migraine prophylaxis previous two month Pregnant woman Participation clinical research study within three month enrolment plan participation time clinical investigation Employees study site sponsor directly involve conduct study , immediate family member individual Headache migraine episode within 48 hour prior first treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>